China Universal Asset Management Company’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
Other funds holding HUMA
AP
DKCM
GPP
China Universal Asset Management Company's HUMA Position: Q2 2026 in Review
China Universal Asset Management Company increased its Humacyte (HUMA) stake by 3.2% in Q2 2026, buying an estimated $1K and bringing the position to 35,334 shares worth $27.6K. The position accounts for ﹤0.01% of the portfolio, ranked #489.
China Universal Asset Management Company first reported a position in HUMA in Q3 2022 and has held it in 16 quarters since. The position peaked at $138K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.
- China Universal Asset Management Company held 35,334 shares of Humacyte worth $27.6K as of Q2 2026.
- China Universal Asset Management Company bought 1,085 Humacyte shares in Q2 2026, an estimated $1K.
- Humacyte made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #489 holding.
- China Universal Asset Management Company first reported a position in Humacyte in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Humacyte position peaked at $138K in Q4 2024.
- 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.